DVHGFDevonian Health Group Inc.

About Devonian Health Group Inc. (DVHGF)

Devonian Health Group Inc. (DVHGF) is a Biotechnology company headquartered in Montmagny, QC, Canada whose shares trade over-the-counter on the OTCQB tier.

Devonian Health Group Inc. is a late-stage botanical pharmaceutical corporation with novel therapeutic approaches to targeting unmet medical needs. Devonian's core strategy is to develop prescription botanical drugs from plant materials and algae for the treatment of inflammatory-autoimmune diseases including but not limited to ulcerative colitis and atopic dermatitis.

Products and services

Devonian Health Group Inc. is a late-stage botanical pharmaceutical corporation with novel therapeutic approaches to targeting unmet medical needs. Devonian's core strategy is to develop prescription botanical drugs from plant materials and algae for the treatment of inflammatory-autoimmune diseases including but not limited to ulcerative colitis and atopic dermatitis.

DVHGF key facts

Ticker symbol

DVHGF

Market tier

OTCQB

Sector

Healthcare

Industry

Biotechnology

Headquarters

Montmagny, QC, Canada

Country of incorporation

CA

Year of incorporation

2015

Employees

7

Estimated market cap

$26.68M (as of May 9, 2025)

Shares outstanding

148,222,531

Reporting standard

International Reporting: TSX Venture Exchange

Audit status

Audited

Fiscal year end

7/31

Latest filing

Quarterly Report (Oct 31, 2024)

Devonian Health Group Inc. leadership

• Andre Boulet — COO, CSO
• Pierre J. Montanaro — President
• Luc Gregoire — President
• Viktoria Krasteva — CFO
• Shelene Watson — Other
• Allison Kaufman — Other

Explore more: Biotechnology stocks · Healthcare sector · OTCQB stocks · OTC stocks starting with D